These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 2858137
41. New drug helps relieve chemotherapy-related symptoms. FDA Consum; 2003; 37(4):3. PubMed ID: 12971326 [No Abstract] [Full Text] [Related]
42. [Nausea and vomiting in cytostatic therapy of melanoma patients with the use of metoclopramide and corticosteroid or ondansetron]. Czeglédi F, Baki M. Orv Hetil; 1994 Oct 30; 135(44):2415-9. PubMed ID: 7970661 [Abstract] [Full Text] [Related]
45. [Prochlorperazine Spofa in the therapy and prevention of nausea and vomiting following cytostatics]. Klener P. Cas Lek Cesk; 1979 Apr 06; 118(14):436-8. PubMed ID: 455360 [No Abstract] [Full Text] [Related]
46. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J. J Clin Oncol; 2006 Sep 20; 24(27):4472-8. PubMed ID: 16983116 [Abstract] [Full Text] [Related]
47. Nausea and vomiting, quality of life, and the oncology nurse. Grant M. Oncol Nurs Forum; 1997 Aug 20; 24(7 Suppl):5-7. PubMed ID: 9282375 [No Abstract] [Full Text] [Related]
48. Pressure prevents nausea. Stannard D. Nurs Times; 1997 Aug 20; 85(4):33-4. PubMed ID: 2928174 [No Abstract] [Full Text] [Related]
49. Dexamethasone in the treatment of nausea and vomiting from cancer chemotherapy. Winokur SH, Baker JJ, Lokey JL, Price NA, Bowen J. J Med Assoc Ga; 1981 Apr 20; 70(4):263-4. PubMed ID: 7012258 [No Abstract] [Full Text] [Related]
51. Optimal combination therapy with Navoban (tropisetron) in patients with incomplete control of chemotherapy-induced nausea and vomiting. The Belgian Navoban Group. Van Belle SJ, Cocquyt VF, Bleiberg H, Canon JL, Buyse M, Hulstaert F, De Witte M, De Keyser P, Westelinck K. Anticancer Drugs; 1995 Feb 20; 6 Suppl 1():22-30. PubMed ID: 7749166 [Abstract] [Full Text] [Related]
52. Conditionability of cancer chemotherapy patients. Ingle RJ, Burish TG, Wallston KA. Oncol Nurs Forum; 1984 Feb 20; 11(4):97-102. PubMed ID: 6566342 [No Abstract] [Full Text] [Related]
53. Aprepitant--where do we stand in the control of chemotherapy-induced nausea and vomiting? Sarcev T, Secen N, Zaric B, Milovancev A. J BUON; 2008 Feb 20; 13(3):333-9. PubMed ID: 18979546 [Abstract] [Full Text] [Related]
54. The clinical role of granisetron (Kytril) in the prevention of chemotherapy-induced emesis. Perez EA, Gandara DR. Semin Oncol; 1994 Jun 20; 21(3 Suppl 5):15-21. PubMed ID: 8042032 [No Abstract] [Full Text] [Related]
57. Control of nausea and vomiting in chemotherapy patients. Four effective behavioral methods. Redd WH. Postgrad Med; 1984 Apr 20; 75(5):105-7, 110-3. PubMed ID: 6143308 [No Abstract] [Full Text] [Related]
58. Behavioral intervention for reducing chemotherapy-related nausea and vomiting in adolescents with cancer. Lebaron S, Zeltzer L. J Adolesc Health Care; 1984 Jul 20; 5(3):178-82. PubMed ID: 6735833 [Abstract] [Full Text] [Related]
59. Using a simple diary for management of nausea and vomiting during chemotherapy. Barak F, Amoyal M, Kalichman L. Clin J Oncol Nurs; 2013 Oct 20; 17(5):479-81. PubMed ID: 24080046 [Abstract] [Full Text] [Related]
60. Conditioned side effects induced by cancer chemotherapy: prevention through behavioral treatment. Burish TG, Carey MP, Krozely MG, Greco FA. J Consult Clin Psychol; 1987 Feb 20; 55(1):42-8. PubMed ID: 3553262 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]